Source:http://linkedlifedata.com/resource/pubmed/id/20434776
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2010-6-11
|
pubmed:abstractText |
A new insulin-enhancing oxovanadium complex 5-chloro-salicylaldhyde ethylenediamine oxovanadium (V) ([V(2)O(2)(mu-O)(2)L(2)]) has been synthesized. The complex was characterized by a variety of physical methods, including X-ray crystallography. The X-ray diffraction analysis show a dinuclear complex of two six-coordinate vanadium centers doubly bridged by the oxygen atoms of the Schiff base ligand with a V(2)O(2) diamond core. The complex was administered intragastrically to STZ-diabetic rats for 2 weeks. The biological activity results show that the complex at the dose of 10.0 and 20.0 mg V kg(-1), could significantly decrease the blood glucose level and ameliorate impaired glucose tolerance in STZ-diabetic rats. That results suggested that the complex exerts an antidiabetic effect in STZ-diabetic rats. Furthermore, the complex ([V(2)O(2)(mu-O)(2)L(2)]) had permeability above 10(-5)cm/s. The experimental results suggested that the vanadium complex permeates via a passive diffusion mechanism. It was also suggested the complex with salen-type ligands has good lipophilic properties and better oral administration. The cytotoxicity of the complex ([V(2)O(2)(mu-O)(2)L(2)]) on Caco-2 cells was measured by a decrease of cell viability using the MTT assay suggesting that the chlorine atom at C4 of complex [V(2)O(2)(mu-O)(2)L(2)] increased cytotoxicity for vanadium complexes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Vanadates,
http://linkedlifedata.com/resource/pubmed/chemical/Vanadium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1873-3344
|
pubmed:author | |
pubmed:copyrightInfo |
(c) 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
851-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:20434776-Animals,
pubmed-meshheading:20434776-Blood Glucose,
pubmed-meshheading:20434776-Caco-2 Cells,
pubmed-meshheading:20434776-Cell Survival,
pubmed-meshheading:20434776-Diabetes Mellitus, Experimental,
pubmed-meshheading:20434776-Humans,
pubmed-meshheading:20434776-Hypoglycemic Agents,
pubmed-meshheading:20434776-Insulin,
pubmed-meshheading:20434776-Male,
pubmed-meshheading:20434776-Molecular Structure,
pubmed-meshheading:20434776-Rats,
pubmed-meshheading:20434776-Rats, Sprague-Dawley,
pubmed-meshheading:20434776-Vanadates,
pubmed-meshheading:20434776-Vanadium
|
pubmed:year |
2010
|
pubmed:articleTitle |
Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
|
pubmed:affiliation |
Deparment of Chemistry, Yunnan University, Kunming 650091, China. xmj7193@yahoo.com.cn
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|